Glucose Hexokinase (Liquid) Reagent

  • Modèle / numéro de série
    Lot: N0702011K, Exp. 10/2014; N0702012, Exp. 10/2014; N0702013K, Exp. 10/2014; P010201K, Exp. 04/2015; P010202K, Exp. 04/2015; P010203K, Exp. 04/2015; P010204K, Exp. 04/2015; P010205K, Exp. 04/2015; P010206K, Exp. 04/2015; P0402015K, Exp. 07/2015; P0402016K, Exp. 07/2015; P050207K, Exp. 08/2015; P050208K, Exp. 08/2015; P050209K, Exp. 08/2015; P0502010K, Exp. 08/2015; P0502011K, Exp. 08/2015; P0502012K, Exp. 08/2015; P0502013K, Exp. 08/2015; P0502014K, Exp. 08/2015; and P0802017K, Exp. 11/2015.
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution -- US, including the states of NV, TN, TX, FL, GA, NY, NC, CA, MN, OR and Puerto Rico; and, the countries of France, Jamaica, Haiti, Cayman Islands, Trinidad & Tobago, and Ghana.
  • Description du dispositif
    Glucose Hexokinase (Liquid) Reagent || For the in vitro quantitative determination of Glucose in serum.
  • Manufacturer
  • 1 Event

Fabricant

  • Adresse du fabricant
    JAS Diagnostics Inc., 14100 Nw 57th Ct, Miami Lakes FL 33014-3107
  • Société-mère du fabricant (2017)
  • Source
    USFDA

Un dispositif médical avec un nom similaire

En savoir plus sur les données ici

  • Modèle / numéro de série
    Model Catalog: GLU2-125 (Lot serial: N0602010K)
  • Description du dispositif
    GLUCOSE HEXOKINASE (LIQUID) REAGENT
  • Manufacturer